Chemerin as an early marker of metabolic syndrome

Joanna Roguska; Agnieszka Zubkiewicz-Kucharska

eISSN: 2083-8441
ISSN: 2081-237X

Pediatric Endocrinology Diabetes and Metabolism

Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

Journal integrated with

1/2018
vol. 24

Send email

Copy url:

abstract:

Case report

Chemerin as an early marker of metabolic syndrome

Joanna Roguska

,

Agnieszka Zubkiewicz-Kucharska

Pediatr Endocrino Diabetes Metab 2018;24,1:45-51

Online publish date: 2018/08/06

View full text Get citation

Chemerin (CHEM) is a protein synthesized primarily by adiposse tissue and liver. CHEM acts both paracrine and autocrine, stimulating adipocytes maturation and differentiation. In addition to its hormonal function, CHEM acts as a chemoattractant for immune cells, regulating the innate and acquired inflammatory response. Its pleiotropic properties also affect the carbohydrates and lipids metabolism. High concentrations of CHEM are observed in people with obesity, type 2 diabetes, hypertension, and hyperlipidemia – components of the metabolic syndrome. Therefore CHEM also may be considered as an early predictive marker for diagnosing metabolic syndrome, also in adolescence and childhood.

keywords:

Chemerin as an early marker of metabolic syndrome

Joanna Roguska , Agnieszka Zubkiewicz-Kucharska

chemerin, metabolic syndrome, obesity, diabetes

Joanna Roguska

,

Agnieszka Zubkiewicz-Kucharska